-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-150-section-5-appendix-1-tables-1-5.pdf
October 22, 2013 - whenever feasible, the recommendations
found in the consensus statement put forth by the American Diabetes … Table 2)
Clinical Guideline
“Careful attention should be given to the increased risk of developing diabetes … baseline and follow-up symptom, side effect, and laboratory
monitoring as indicated….The American Diabetes … Not specified
T-MAY (2012)
Center for Education and Research
on Mental Health Therapeutics—
Treatment … Treatments
and ongoing management. Pediatrics. 129(6):e1577–86.
-
www.ahrq.gov/sites/default/files/2024-01/soumerai-report.pdf
January 01, 2024 - We determined presence or absence of diabetes, based
on one or more dispensed diabetes medications or … Our data suggest that the increased use of guideline-adherent
therapies did not affect blood pressure … Engaging physicians to switch patients’ therapies likely requires
more intensive intervention strategies … We found that both
individual and group academic detailing can increase the use of guideline-based
treatments … Diabetes Care 2003; 26:3061-3066.
23. van Eijk ME, Avorn J, Porsius AJ, de Boer A.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZYao53-sqRb6oZzKzDmjjt
December 01, 2003 - Task Force
(USPSTF) recommended periodic height and
weight measurement.7 Increased obesity prevalence,
therapeutic … dislocation,
leakage, or slippage (0.4%–8%).100,163–165,167,168,170–172,177,178
Discussion
Efficacy of Therapeutic … All obesity therapies carry promise and burden,
which must be balanced in clinical decision-making. … Role of
orlistat in the treatment of obese patients with type
2 diabetes. … An operation proves
to be the most effective therapy for adult-onset
diabetes mellitus.
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
June 01, 2014 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … Because of even greater morbidity risk, therapeutic intervention is considered to be urgently needed … patient’s diabetes status. … for diabetes is much lower than
that intended for obesity treatment: liraglutide is currently approved
-
digital.ahrq.gov/health-it-tools-and-resources/ahrq-funded-project-resources-archives/telewound-care-network-patien-0
January 01, 2023 - Description
Sample informed consent document for study involving wound care treatment … and underlying diabetes.
-
digital.ahrq.gov/ahrq-funded-projects/computer-assisted-medication-and-patient-information-interface-campii/annual-summary/2012
January 01, 2012 - Funding Amount
$299,998
Summary: Although many studies show that the complications and costs of diabetes … can be reduced by controlling glucose and other risk factors, many people with diabetes do not achieve … and providers, thereby improving treatment outcomes and reducing complications. … This information was provided to clinicians so they could make more-informed therapeutic decisions for … Target Population: Adults, Chronic Care*, Diabetes, Racial or Ethnic Minorities*: African-American
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-235-section-1-tables-1-2.pdf
June 02, 2025 - Pediatric Dermatology 207NP0225X
Procedural Dermatology 207NS0135X
Endocrinology Endocrinology, Diabetes … Office 11
Home 12
Mobile Unit 15
Outpatient Hospital 22
Ambulatory Surgical Center 24
Military Treatment … Federally Qualified Health Center 50
Community Mental Health Center 53
Non-residential Substance Abuse Treatment … Immunization Center 60
Comprehensive Outpatient Rehabilitation Facility 62
End-stage Renal Disease Treatment
-
integrationacademy.ahrq.gov/sites/default/files/2020-07/Controlling_High_Blood_Pressure.pdf
January 01, 2020 - - Patients 60–85 years of age with a diagnosis of diabetes whose BP was <140/90 mm Hg. … - Patients 60–85 years of age without a diagnosis of diabetes whose BP was <150/90 mm
Hg. … years of age as of the end of the measurement year (e.g., December 31)
and flagged with a diagnosis of diabetes … as of the end of the measurement year (e.g., December 31)
and flagged as not having a diagnosis of diabetes … Risk Adjustment:
No
Classification:
National Quality Strategy Priorities:
Prevention and Treatment
-
digital.ahrq.gov/ahrq-funded-projects/computer-assisted-medication-and-patient-information-interface-campii/annual-summary/2011
January 01, 2011 - can be reduced by controlling glucose and other risk factors, many people with diabetes do not achieve … and providers, thereby improving treatment outcomes and reducing complications. … information interface is designed to collect complete and accurate information so providers can make informed therapeutic … decisions for their patients who have diabetes and the associated major cardiovascular risk factors. … Target Population: Adults, Chronic Care*, Diabetes, Racial or Ethnic Minorities*: African-American
-
www.ahrq.gov/prevention/resources/vision/resources/vision1.html
October 01, 2002 - Further, as the prevalence and incidence of diabetes increases, particularly among those younger than … Services provided to target the disabling condition, including (1) medical/surgical treatment, (2) therapeutic … Further, there is a lack of evidence regarding the association between therapeutic intensity (measured … absence of clearly superior alternatives, choices must be made between therapies without proven superiority … Early detection and treatment can prevent up to 90 percent of cases of diabetes-related blindness.
-
digital.ahrq.gov/care-setting/integrated-delivery-network
January 01, 2023 - R01 HS022087
Principal Investigator(s)
Singh, Hardeep
Feedback of Treatment … Description
This study looked at patients at high risk for cardiovascular disease who would benefit from treatment … between electronic health record use and care coordination and clinical care quality for patients with diabetes … a patient secure messaging application for patients with depression, congestive heart failure, and diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-heart_research-protocol.pdf
April 18, 2012 - with SMI; they receive fewer preventive medical
services12,13 and less frequent guideline-concordant treatment … (standard
treatment)
Antipsychotic medication switching
Patient education
Exercise program
Nutrition … mellitus
Standard pharmacological treatment
(multiple agents)
Antipsychotic medication switching … studies, we will perform subgroup analyses and/or meta-regression analyses to
examine variability in treatment … Mellitus/prevention and control"[Mesh] OR “diabetes management”[tiab] OR
"Behavior Therapy"[Mesh] OR
-
psnet.ahrq.gov/node/35620/psn-pdf
February 03, 2011 - Excess dosing of antiplatelet and antithrombin agents in
the treatment of non–ST-segment elevation acute … Excess dosing of antiplatelet and antithrombin agents in the
treatment of non-ST-segment elevation acute … https://psnet.ahrq.gov/issue/excess-dosing-antiplatelet-and-antithrombin-agents-treatment-non-st-segment … -
elevation-acute
Treatment of acute coronary syndromes (ACS) benefits from extensive research outlining … seem directed at
vulnerable populations such as elderly patients with specific comorbidities (eg, diabetes
-
digital.ahrq.gov/sites/default/files/docs/publication/r36hs021082-graetz-final-report-2012.pdf
January 01, 2012 - Department of Health and Human Services of a particular drug, device, test, treatment, or
other clinical … physicians (e.g., primary care and specialists),
sites of care (e.g., inpatient and outpatient), and treatments … access to timely and complete information (OR=2.09, 95% CI:
1.41-3.09) and clinician agreement on treatment … Likewise, for cohesive teams, reported
clinician agreement on treatment goals and plans was higher with … Booth, The
Treatment of Unrelated Disorders in Patients with
Chronic Medical Diseases.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/vTJ_Zj3TAkhx45wWUDtNyt
May 01, 2021 - underprediction
in disadvantaged communities10,11 that could lead to underutiliza-
tion of preventive therapies … fixed-dose treatment strategies. … • Definitively determining whether statin therapy is associated with
increased risk of diabetes in … Cardiovascular benefits and diabetes risks
of statin therapy in primary prevention: an analysis
from … Statin therapy: diabetes mellitus risk
and cardiovascular benefit in primary prevention.
-
meps.ahrq.gov/data_files/publications/st34/stat34.pdf
January 01, 2001 - Stagnitti, MPA
Introduction
Diabetes is an increasingly prevalent disease in the U.S. community ( … community population were told by a physician that they had diabetes. … In 2000, over $18 billion was
spent on health care for persons with diabetes. … This Statistical Brief presents preliminary estimates of the relationship between diabetes, obesity, … Clinical Guidelines on the
Identification, Evaluation, and Treatment of Overweight and Obesity in Adults
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs019792-li-final-report-2014.pdf
January 01, 2014 - Studies have shown that timely DR diagnosis and treatment can significantly
reduce the risk of severe … Methods
Overall Research Design
Studies have shown that timely DR diagnosis and treatment can … Current Diabetes Reports, 13(4), 453-459, 2013. … [2] Early Treatment and Detection of Diabetic Retinopathy Study Group. 1991. … Klein (ed.), Diabetes in America,2nd ed.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician-2016.pdf
January 01, 2016 - setting, problem-solving,
motivational interviewing, coping skills training, and
cognitive behavioral therapy … In the United States, type 2
diabetes mellitus (T2DM) accounts for 90 to 95 percent of
diabetes cases … DSME, which
provides education on diabetes-related topics (including
the disease process, treatment … quality of life, diabetes
distress,a and diabetes-related complications. … a Diabetes distress is a unique set of emotional issues experienced by
patients with diabetes.
-
psnet.ahrq.gov/node/49758/psn-pdf
April 01, 2016 - oral diabetes agents and other non-insulin
therapies in most circumstances. … , acute renal failure, and receipt of IV
contrast.(3)
In most instances, insulin is the preferred treatment … Association inpatient
glycemic control guidelines were revised to initiate insulin therapy for persistent … to keep target glucose in the controlled, rather than tight, range.(3) Specifically, once insulin
therapy … Intensive insulin therapy in critically ill patients. N Engl
J Med. 2001;345:1359-1367.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
April 26, 2022 - Cardiovascular disease (CVD) is the leading cause of death in the US. 1 Aspirin has long been a recommended therapy … Optimal Treatment (HOT) study. … Low-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis … Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes … Annual risk of major bleeding among persons without cardiovascular disease not receiving antiplatelet therapy